Skip to main content
. 2024 Mar 7;24:55. doi: 10.1186/s12894-024-01441-8

Table 5.

The NMA presents the impact of each intervention for recurrence-free survival

placebo 0.90 (0.51,1.58) 0.93 (0.68,1.27) 0.93 (0.30,2.91) 0.79 (0.38,1.64)
0.89 (0.51,1.58) sorafenib NA NA NA
0.93 (0.68,1.27) 1.04 (0.54,1.99) IL2 + IFN + 5FU NA NA
0.93 (0.30,2.91) 1.04 (0.29,3.72) 1.00 (0.31,3.26) tegafur + uracil NA
0.79 (0.38,1.64) 0.89 (0.35,2.23) 0.85 (0.39,1.88) 0.85 (0.22,3.27) thalidomide